154871 event 1347893527 1475891997 <![CDATA[Biosimilars: Where Do We Stand?]]> Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, what are the ethical implications of these products?  How will they impact clinical supply chain?  What are the financial implications?  Join a panel of experts as they explore these and other questions on biosimilars during this luncheon seminar.
Panelists:

Amir Emamifar, PharmD - Associate Administrator Pharmaceutical Services, Emory Healthcare
Yaniv Heled, JSD, LLM - Assistant Professor of Law, Georgia State University College of Law
Ashish Dugar PhD, MBA - Head, Medicines Development Group, Biosimilars Business Unit, Pfizer

Moderator:
Joel Zivot, MD, FRCP – Assistant Professor Anesthesiology & Surgery, Emory University School of Medicine, and Medical Director, Cardiothoracic ICU, Emory University Hospital Midtown

ACHE CEUs:
1.5 hours ACHE Qualified Education Credit (formerly “Category 2”)

Download the Flyer for more details & speaker biographies

Registration:

Registrations for this event are being collected by the Georgia Association of Healthcare Executives. CLICK HERE TO REGISTER.

ACHE/GaBio Member ..... $35
Non-Member ................ $45
Student Member .......... $20
Student Non-Member..... $25

For information contact: GAHE Administrator Karen Manno or call 678-264-8354

A joint program with the Georgia Association of Healthcare Executives

]]> Biosimilars: Where Do We Stand? - A Georgia Bio luncheon seminar

]]> Karen Manno

]]> <![CDATA[]]> http://gahe.ache.org/x49.xml 1292 1795 43831 5815